Mr. Speaker, again, our government continues to be a large player in pharmaceutical benefits, spending approximately $600 million last year to cover pharmaceutical products, medical supplies and equipment for diverse populations and individuals, including first nations and Inuit. The responsibility is with the provincial and territorial governments to decide whether or not to provide their residents with publicly financed drug therapy.
In the House of Commons on September 20th, 2010. See this statement in context.